✦ LIBER ✦

1123 ORAL Panitumumab, a fully human antibody, combined with paclitaxel and carboplatin versus paclitaxel and carboplatin alone for first line advanced non-small cell lung cancer (NSCLC): a primary analysis

Book ID: 123168055
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 149 KB
Volume: 3
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(05)81418-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9068 Analysis of experience with cisplat

9068 Analysis of experience with cisplatin or carboplatin in first line combination chemotherapy with paclitaxel for advanced and metastatic Non Small Cell Lung cancer (NSCLC)

✍ Gamaz, M.; Bouzid, K. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

227 Paclitaxel, carboplatin and mitomyci

227 Paclitaxel, carboplatin and mitomycin as first-line treatment in patients (PTS) with advanced non-small cell lung cancer (NSCLC)

✍ Zarogoulidis, K.; Papagiannis, A.; Constantinidis, T.C.; Vogiatzis, A.K.; Pella, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 152 KB

6508 ORAL CP-751, 871, an anti-IGF-IR an

6508 ORAL CP-751, 871, an anti-IGF-IR antibody, in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC): A phase Ib/randomized phase II, non-comparative, open label trial

✍ Paz-Ares, L.; Pollak, M.N.; Eisenberg, P.D.; Blakely, L.J.; Haluska, P.; Cohen, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 77 KB

A phase I/randomized phase II, non-compa

A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC)

✍ Roger B. Cohen; Corey J. Langer; George Rajan Simon; Peter David Eisenberg; John 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 387 KB

A phase II study of carboplatin and pacl

A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)

✍ Giorgio, Carmelo Giannitto; Pappalardo, Alessandro; Russo, Antonio; Giuffrida, D 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Randomized Phase II Study of Vandetanib

Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non-Small-Cell Lung Cancer

✍ Heymach, J. V.; Paz-Ares, L.; De Braud, F.; Sebastian, M.; Stewart, D. J.; Eberh 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 192 KB